Chinese Journal of Antituberculosis ›› 2026, Vol. 48 ›› Issue (6): 813-820.doi: 10.19982/j.issn.1000-6621.20250405
• Original Articles • Previous Articles Next Articles
Zhang Yue, Huang Jinpeng, Gao Dan(
), Ling Lin
Received:2025-10-15
Online:2026-06-10
Published:2026-05-25
Contact:
Gao Dan
E-mail:332849649@qq.com
Supported by:CLC Number:
Zhang Yue, Huang Jinpeng, Gao Dan, Ling Lin. Status and influencing factors of medication adherence among elderly tuberculosis patients based on digital technologies[J]. Chinese Journal of Antituberculosis, 2026, 48(6): 813-820. doi: 10.19982/j.issn.1000-6621.20250405
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.19982/j.issn.1000-6621.20250405
| 项目 | 服药依从组(139例) | 服药不依从组(66例) | 统计检验值 | P值 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 性别 | χ2=0.621 | 0.431 | ||||||||
| 男性 | 88(63.3) | 38(57.6) | ||||||||
| 女性 | 51(36.7) | 28(42.4) | ||||||||
| 医保类别 | χ2=4.942 | 0.084 | ||||||||
| 医保 | 82(59.0) | 38(57.6) | ||||||||
| 农保 | 50(36.0) | 19(28.8) | ||||||||
| 自费 | 7(5.0) | 9(13.6) | ||||||||
| 文化程度 | χ2=4.098 | 0.129 | ||||||||
| 初中及以下 | 78(56.1) | 45(68.2) | ||||||||
| 中专及高中 | 31(22.3) | 14(21.2) | ||||||||
| 大专及以上 | 30(21.6) | 7(10.6) | ||||||||
| 吸烟 | χ2=4.709 | 0.030 | ||||||||
| 否 | 125(89.9) | 52(78.8) | ||||||||
| 是 | 14(10.1) | 14(21.2) | ||||||||
| 饮酒 | χ2=4.001 | 0.045 | ||||||||
| 否 | 124(89.2) | 52(78.8) | ||||||||
| 是 | 15(10.8) | 14(21.2) | ||||||||
| 婚姻状态 | χ2=0.984 | 0.321 | ||||||||
| 有配偶 | 102(73.4) | 44(66.7) | ||||||||
| 无配偶 | 37(26.6) | 22(33.3) | ||||||||
| 并发高血压 | χ2=0.739 | 0.390 | ||||||||
| 否 | 111(79.9) | 56(84.8) | ||||||||
| 是 | 28(20.1) | 10(15.2) | ||||||||
| 并发糖尿病 | χ2=0.184 | 0.668 | ||||||||
| 否 | 121(87.1) | 56(84.8) | ||||||||
| 是 | 18(12.9) | 10(15.2) | ||||||||
| 血型 | χ2=5.035 | 0.169 | ||||||||
| A | 47(33.8) | 13(19.7) | ||||||||
| B | 22(15.8) | 16(24.2) | ||||||||
| AB | 53(38.1) | 28(42.4) | ||||||||
| O | 17(12.2) | 9(13.6) | ||||||||
| 治疗分类 | χ2=1.985 | 0.159 | ||||||||
| 初治 | 127(91.4) | 56(84.8) | ||||||||
| 复治 | 12(8.6) | 10(15.2) | ||||||||
| 诊断分类 | χ2=1.048 | 0.306 | ||||||||
| 肺结核 | 78(56.1) | 32(48.5) | ||||||||
| 肺外结核 | 61(43.9) | 34(51.5) | ||||||||
| 其他药物过敏史 | χ2=23.639 | <0.001 | ||||||||
| 否 | 136(97.8) | 51(77.3) | ||||||||
| 是 | 3(2.2) | 15(22.7) | ||||||||
| 皮肤过敏反应 | χ2=6.987 | 0.008 | ||||||||
| 否 | 137(98.6) | 57(86.4) | ||||||||
| 是 | 2(1.4) | 9(13.6) | ||||||||
| 胃肠道反应 | χ2=5.504 | 0.019 | ||||||||
| 否 | 126(90.6) | 52(78.8) | ||||||||
| 是 | 13(9.4) | 14(21.2) | ||||||||
| 数字技术随访应答 | χ2=5.965 | 0.015 | ||||||||
| 不佳 | 25(18.0) | 22(33.3) | ||||||||
| 良好 | 114(82.0) | 44(66.7) | ||||||||
| 家庭支持 | χ2=7.504 | 0.023 | ||||||||
| 低家庭支持 | 16(11.5) | 13(19.7) | ||||||||
| 中家庭支持 | 84(60.4) | 45(68.2) | ||||||||
| 高家庭支持 | 39(28.1) | 8(12.1) | ||||||||
| 日常生活能力 | -a | <0.001 | ||||||||
| 不依赖 | 1(0.7) | 2(9.1) | ||||||||
| 轻度依赖 | 4(2.9) | 14(31.8) | ||||||||
| 中度依赖 | 122(87.8) | 49(57.6) | ||||||||
| 重度依赖 | 12(8.6) | 1(1.5) | ||||||||
| BMI[kg/m2,M(Q1,Q3)] | 20.3(18.4,22.7) | 20.1(17.6,22.1) | Z=-1.115 | 0.265 | ||||||
| ALT[U/L,M(Q1,Q3)] | 16(10,25) | 16(10,29) | Z=-0.130 | 0.897 | ||||||
| AST[U/L,M(Q1,Q3)] | 19(16,28) | 23(16,35) | Z=-1.168 | 0.243 | ||||||
| BUN[mmol/L,M(Q1,Q3)] | 4.6(3.5,5.9) | 4.4(3.3,6.8) | Z=-0.219 | 0.826 | ||||||
| SCr[umol/L,M(Q1,Q3)] | 68.5(59.3,79.2) | 66.9(54.5,79.9) | Z=-0.746 | 0.456 | ||||||
| 项目 | β值 | s | P值 | OR (95%CI)值 | |||
|---|---|---|---|---|---|---|---|
| 吸烟 | |||||||
| 否 | 1 | ||||||
| 是 | 0.224 | 0.751 | 0.766 | 1.251(0.287~5.456) | |||
| 饮酒 | |||||||
| 否 | 1 | ||||||
| 是 | -0.17 | 0.761 | 0.824 | 0.844(0.190~3.753) | |||
| 皮肤过敏反应 | |||||||
| 否 | 1 | ||||||
| 是 | 2.795 | 1.160 | 0.016 | 16.357(1.683~158.968) | |||
| 胃肠道反应 | |||||||
| 否 | 1 | ||||||
| 是 | 1.336 | 0.541 | 0.013 | 3.804(1.318~10.978) | |||
| 其他药物过敏史 | |||||||
| 否 | 1 | ||||||
| 是 | 2.378 | 0.938 | 0.011 | 10.782(1.714~67.828) | |||
| 数字技术随访应答 | |||||||
| 不佳 | 1 | ||||||
| 良好 | -1.147 | 0.465 | 0.014 | 0.317(0.128~0.790) | |||
| 家庭支持 | |||||||
| 低 | 1 | ||||||
| 中 | -0.54 | 0.523 | 0.302 | 0.583(0.209~1.624) | |||
| 高 | -2.469 | 0.810 | 0.002 | 0.085(0.017~0.414) | |||
| 日常生活能力 | |||||||
| 重度依赖 | 1 | ||||||
| 中度依赖 | 1.353 | 1.417 | 0.340 | 3.869(0.241~62.163) | |||
| 轻度依赖 | -2.485 | 1.215 | 0.041 | 0.083(0.008~0.901) | |||
| 不依赖 | -3.529 | 1.600 | 0.027 | 0.029(0.001~0.675) | |||
| [1] | 宋媛媛, 李涛, 夏辉, 等. 1997—2023年全国肺结核报告发病流行病学特征. 中国防痨杂志, 2024, 46(10):1198-1208. doi:10.19982/j.issn.1000-6621.20240382. |
| [2] | 屈燕, 李涛, 马文斌, 等. 世界卫生组织《2025年全球结核病报告》解读. 结核与肺部疾病杂志, 2025, 6(6):613-623. doi:10.19983/j.issn.2096-8493.20250178. |
| [3] | 王慧娟, 程瑞霞, 许佳. 肺结核患者服药依从性研究进展. 中国防痨杂志, 2025, 47(9):1212-1219. doi:10.19982/j.issn.1000-6621.20250173. |
| [4] | Shringarpure K, Gurumurthy M, Sagili KD, et al. Patient adherence to tuberculosis tr eatment in the Indian subcontinent: systematic review and meta-synthesis of quali tative research. BMJ Open, 2023, 13(5):e063926. doi:10.1136/bmjopen-2022-063926. |
| [5] | 吴哲渊, 肖文静, 秦楠, 等. 中国结核病数字服药依从性技术应用指南. 中国防痨杂志, 2025, 47(4):385-397. doi:10.19982/j.issn.1000-6621.20250042. |
| [6] | Liu X, Thompson J, Dong H, et al. Digital adherence technologies to improve tuberculosis treatment outcomes in China: a cluster-randomised superiority trial. Lancet Glob Health, 2023, 11(5):e693-e703. doi:10.1016/S2214-109X(23)00068-2. |
| [7] | Hasnan S, Aggarwal S, Mohammadi L, et al. Barriers and enablers of uptake and adherence to digital health interventions in older patients with cancer: A systematic review. J Geriatr Oncol, 2022, 13(8):1084-1091. doi:10.1016/j.jgo.2022.06.004. |
| [8] | World Health Organization. WHO consolidated guidelines on tuberculosis: Module 3: Diagnosis. Geneva: World Health Organization, 2025. |
| [9] | Loretan CG, Wang TW, Watson CV, et al. Disparities in Current Cigarette Smoking Among US Adults With Mental Health Conditions. Prev Chronic Dis, 2022,19:E87. doi:10.5888/pcd19.220184. |
| [10] | 钟丽, 张涛. 饮酒模式的评估及分类. 四川精神卫生, 2015, 28(5):485-488. doi:10.11886/j.issn.1007-3256.2015.05.030. |
| [11] | 周祥, 张庆庆, 贾依娜西·阿扎提, 等. MMAS-8量表调查单中心腹膜透析患者药物依从性现况及影响因素分析. 中国血液净化, 2023, 22(9):675-678. doi:0.3969/j.issn.1671-4091.2023.09.009. |
| [12] | 苏静怡, 杜雨华, 张凤玲, 等. 家庭支持对耐多药肺结核患者治疗依从性和治愈率的影响. 结核病与肺部健康杂志, 2013, 2(4):289-291. doi:10.3969/j.issn.2095-3755.2013.04.015. |
| [13] | 薛凯文, 刘翔翔, 张泽宇, 等. 脑卒中患者日常生活活动能力评定量表反应性研究进展. 康复学报, 2022, 32(4):374-380. doi:10.3724/SP.J.1329.2022.04014. |
| [14] | 张晗, 王丽霞, 魏玉石, 等. 数字化治疗依从性技术在肺结核患者服药管理中的应用效果评价. 中国防痨杂志, 2024, 46(2):158-164. doi:10.19982/j.issn.1000-6621.20230283. |
| [15] | 舒薇, 刘宇红. 矢志革新履践致远:《2024年全球结核病报告》结核病科学研究章节解读. 中国防痨杂志, 2025, 47(2):137-141. doi:10.19982/j.issn.1000-6621.20240559. |
| [16] | Djochie RDA, Anto BP, Opare-Addo MNA. Determinants of adverse reactions to first-line antitubercular medicines: a prospective cohort study. J Pharm Policy Pract, 2023, 16(1):70. doi:10.1186/s40545-023-00577-6. |
| [17] | Ridolfi F, Amorim G, Peetluk LS, et al. Regional Prospective Observational Research in Tuberculosis (RePORT)-Brazil Consortium. Prediction Models for Adverse Drug Reactions During Tuberculosis Treatment in Brazil. J Infect Dis, 2024, 229(3):813-823. doi:10.1093/infdis/jiae025. |
| [18] | Du L, Chen X, Zhu X, et al. Determinants of Medication Adherence for Pulmonary Tuberculosis Patients During Continuation Phase in Dalian, Northeast China. Patient Prefer Adherence, 2020, 14:1119-1128. doi:10.2147/PPA.S243734. |
| [19] | 陈慧军. 抗结核病药物在60岁以上老年肺结核治疗中的不良反应及影响因素分析. 中国社区医师, 2020, 36(33):13-14. doi:10.3969/j.issn.1007-614x.2020.33.006. |
| [20] | Khattak M, Rehman AU, Muqaddas T, et al. Tuberculosis (TB) treatment challenges in TB-diabetes comorbid patients: a systematic review and meta-analysis. Ann Med, 2024, 56(1):2313683. doi:10.1080/07853890.2024.2313683. |
| [21] | 高丹, 王玲华, 黄金鹏, 等. 基于“互联网+”医院-社区-家庭联动模式结核病患者随访方案的构建. 中国防痨杂志, 2024, 46(2):228-238. doi:10.19982/j.issn.1000-6621.20230344. |
| [22] | 闫文华, 陈文君. 数智化健康教育在菌阳肺结核患者陪护者预防管理中的价值. 结核与肺部疾病杂志, 2025, 6(1):73-78. doi:10.19983/j.issn.2096-8493.2024143. |
| [23] | 李国瑜. 数字平台赋能基层慢病管理的作用机制研究. 武汉: 华中科技大学, 2024. doi:10.27157/d.cnki.ghzku.2024.006451. |
| [24] | 黄海燕, 陈怡冰, 李冉然, 等. 家庭健康对中老年慢性病患者服药依从性的影响:领悟社会支持的中介作用. 中国老年学杂志, 2024, 44(19):4840-4843. doi:10.3969/j.issn.1005-9202.2024.19.053. |
| [25] | 陈一萌, 郭银宁, 朱涵菲, 等. 家庭支持视角下萨提亚沟通模式在护理领域中的应用进展. 中华护理杂志, 2024, 59(19):2413-2419. doi:10.3761/j.issn.0254-1769.2024.19.016. |
| [26] | 张锐, 冯绘绘, 勾阳阳, 等. 家庭关怀度与服药信念在老年缺血性卒中患者药物素养和服药依从性之间的中介作用. 护理学杂志, 2024, 39(8):20-24. doi:10.3870/j.issn.1001-4152.2024.08.020. |
| [27] | Kim G, Hwang M, Lee S, et al. Need for and Acceptance of Digital Health Interventions for Self-Management Among Older Adults Living Alone: A Mixed-Methods Approach. Asian Nurs Res (Korean Soc Nurs Sci), 2025, 19(1):86-95. doi:10.1016/j.anr.2024.12.007. |
| [28] | Yagi M, Shindo Y, Mutoh Y, et al. Factors associated with adverse drug reactionsor death in very elderly hospitalized patients with pulmonary tuberculosis. Sci Rep, 2023, 13(1):6826. doi:10.1038/s41598-023-33967-6. |
| [29] | Jo K, Kawashima M, Suzuki J, et al. The Treatment and Prognosis of Older Tuberculosis Patients with a Poor Perfor-mance Status Caused by Underlying Diseases. Intern Med, 2023, 62(12):1743-1748. doi:10.2169/internalmedicine.0467-22. |
| [1] | Reyhangul·Aken , Muratjan·Amat , Gao Xusheng, Ding Caihong, Zeng Yi, Chen Yu, Bai Yan, Fan Lin. Analysis of influencing factors of malnutrition and treatment outcomes among elderly patients with pulmonary tuberculosis aged 60 years and above [J]. Chinese Journal of Antituberculosis, 2026, 48(6): 751-759. |
| [2] | Jiangxi Chest Hospital/Jiangxi Provincial Key Laboratory of Tuberculosis, Chinese Antituberculosis Association, Guangzhou National Laboratory. Expert consensus on the diagnosis and treatment of breast tuberculosis [J]. Chinese Journal of Antituberculosis, 2026, 48(6): 737-750. |
| [3] | Xu Yong, Zhou Teng, Liu Junjia. Construction and validation of a risk prediction model for restenosis after interventional treatment of tuberculous airway stenosis [J]. Chinese Journal of Antituberculosis, 2026, 48(6): 760-768. |
| [4] | Fan Jiahua, Yan Liang, Chen Hua, Lu Chunli, Wang Min, Huang Yaling, Li Yan. Association between nutritional risk, inflammatory indicators, and glycemic control in patients with tuberculosis complicated by diabetes mellitus [J]. Chinese Journal of Antituberculosis, 2026, 48(6): 769-778. |
| [5] | Wang Xinyan, Pan Hongfang, Mei Xue, Zhang Yi, Liu Jie. Analysis of the characteristics of peripheral blood clinical detection indicators in patients with pulmonary tuberculosis complicated with osteoarticular tuberculosis [J]. Chinese Journal of Antituberculosis, 2026, 48(6): 779-786. |
| [6] | Li Jing, Chen Shuangshuang, Chen Chunhua, Yang Guoxiang, Yang Chengnao, Zheng Luyun, Tan Chengjian, Li Chuanyou, Li Jie, Zhou Peifu, Dai Xiaowei. Screening of anti-tuberculosis activity and analysis of chemical constituents of the Ethnomedicine Botrychium ternatum [J]. Chinese Journal of Antituberculosis, 2026, 48(6): 787-794. |
| [7] | Xia Lu, Mu Tingting, Cai Qiujie, Ma Yan, Gong Mengmeng, Ye Dan, Zhang Wei. Analysis of Traditional Chinese Medicine syndrome characteristics in 619 severe pulmonary tuberculosis patients based on syndrome element differentiation [J]. Chinese Journal of Antituberculosis, 2026, 48(6): 795-802. |
| [8] | Guo Chenhao, Liu Xinyu, Zhan Sirui, Wang Lili, Ma Mengting, Li Xiumei, Qi Linping, Li Weiping. Interferon-gamma release assays for diagnosing extrapulmonary tuberculosis in adults: a systematic review and Meta-analysis [J]. Chinese Journal of Antituberculosis, 2026, 48(6): 803-812. |
| [9] | Zhang Yaying, Wang Senlu, Guliziba Kuerbanjiang, Abulikemu Aili, Liang Chen, Yuan Shuanglong, Li Caihong, Cao Mingqin. Analysis of influencing factors and pathways on psychological burden associated with pulmonary tuberculosis treatment in Southern Xinjiang Region of the Xinjiang Uygur Autonomous Region [J]. Chinese Journal of Antituberculosis, 2026, 48(6): 821-829. |
| [10] | Du Xilong, Maiwulajiang·Yimamu , Na Yan, Paziliya·Yasheng , Guo Gang, Maiweilanjiang·Abulimiti , Zhang Liping, Zheng Yanling. Construction of an optimal prediction model for treatment outcomes in retreatment pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2026, 48(6): 830-839. |
| [11] | Liu Lin, Yin Xiaocheng, Zhang Xiaofo, Liang Linlong, Yang Ju. Global burden of tuberculosis in children aged 0-14 years, 1990—2023, and trend projections for 2024—2050 [J]. Chinese Journal of Antituberculosis, 2026, 48(6): 840-848. |
| [12] | Huang Aichun, Lan Yanqun, Xu Chaoyan, Zhang Jie, Li Weiwen, Zhu Qingdong, Xie Zhouhua. Analysis of related factors influencing interferon-gamma release assay results in patients having coexistent tuberculosis and acquired immune deficiency syndrome [J]. Chinese Journal of Antituberculosis, 2026, 48(6): 849-855. |
| [13] | Jiang Xuefeng, Zhou Linjun, Sun Yan, Jiang Mingxia, Ma Ling, Mei Li, Liu Dongxin. Analysis of drug resistance gene mutation characteristics in Mycobacterium tuberculosis strains from five northwestern provinces of China [J]. Chinese Journal of Antituberculosis, 2026, 48(6): 856-864. |
| [14] | Yuan Shaoying, Cui Zhongfeng, Du Jiang, Cao Xuefang, Feng Boxuan, He Yijun, Li Zihan, Zhao Yaqi, Yu Yilin, Gao Lei, Xin He’nan, Li Hongzhi. The application value of the QuantiFERON-TB Gold Plus for active pulmonary tuberculosis diagnosis and treatment response monitoring [J]. Chinese Journal of Antituberculosis, 2026, 48(6): 865-873. |
| [15] | Qiao Xiaobo, Li Jing, Wang Baoqian, Zhou Weidong, Wang Fei, Zhang Qibo, Li Tongxia. Study on the diagnostic value of GeneXpert MTB/RIF and BACTEC MGIT 960 in bronchoalveolar lavage fluid combined with peripheral blood IGRA testing for etiologically negative pulmonary tuberculosis diagnosis [J]. Chinese Journal of Antituberculosis, 2026, 48(6): 874-881. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
京公网安备11010202007215号
Total visitors: Visitors of today: Now online:
This work is licensed under Creative Commons Attribution 3.0 License.